Inventor · disambiguated record
Evy Lundgren-Akerlund
Also filed as: LUNDGREN ÅKERLUND EVY · LUNDGREN-AAKERLUND EVY · LUNDGREN-AEKERLUND EVY · LUNDGREN-AKERLUND EVY
12 granted patents·7 pending applications·68 citations·filing 1999–2016
90Inventor score
Top patents by PatentIndex Score
19 records- 0183US10087253B2Monoclonal antibody capable of binding integrin alpha 10 beta 1XINTELA AB·Filed 2016·Granted Oct 2, 2018·5 cites·10 claims
- 0283US8563255B2Monoclonal antibody capable of binding integrin alpha 10 beta 1LUNDGREN-AEKERLUND EVY·Filed 2011·Granted Oct 22, 2013·5 cites·12 claims
- 0382US8048991B2Antibody to an integrin heterodimer and/or a subunit thereofXINTELA AB·Filed 2006·Granted Nov 1, 2011·9 cites·10 claims
- 0480US8105791B2Marker for stem cells and its useLUNDGREN-AAKERLUND EVY·Filed 2010·Granted Jan 31, 2012·5 cites·5 claims
- 0578US8012696B2Monoclonal antibody capable of binding integrin alpha 10 beta 1XINTELA AB·Filed 2008·Granted Sep 6, 2011·3 cites·6 claims
- 0677US8895253B2Integrin heterodimer and a subunit thereofXINTELA AB·Filed 2012·Granted Nov 25, 2014·2 cites·18 claims
- 0772US7452677B2Monoclonal antibody capable of binding integrin alpha 10 beta 1CARTELA R & D AB·Filed 2004·Granted Nov 18, 2008·21 cites·10 claims
- 0866US10081666B2Integrin heterodimer and a subunit thereofXINTELA AB·Filed 2014·Granted Sep 25, 2018·0 cites·12 claims
- 0963US7749710B2Marker for stem cells and its useXINTELA AB·Filed 2003·Granted Jul 6, 2010·4 cites·20 claims
- 1062US7029858B1Integrin heterodimer and a subunit thereofCARTELA AB·Filed 1999·Granted Apr 18, 2006·14 cites·10 claims
- 1161US9365649B2Monoclonal antibody capable of binding integrin alpha 10 beta 1XINTELA AB·Filed 2013·Granted Jun 14, 2016·0 cites·6 claims
- 1257US2008159956A1Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formationHANSA MEDICAL AB·Filed 2008·Application pending·0 cites
- 1355US2012136141A1Integrin Heterodimer And A Subunit ThereofLUNDGREN-AKERLUND EVY·Filed 2011·Application pending·0 cites
- 1454US2005255182A1Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formationCARTELA AB·Filed 2003·Application pending·0 cites
- 1550US10994022B2Detection and treatment of malignant tumours in the CNSXINTELA AB·Filed 2016·Granted May 4, 2021·0 cites·22 claims
- 1648US2010055114A1Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnoverLUNDGREN-AKERLUND EVY·Filed 2007·Application pending·0 cites
- 1747US2011256061A1Binding agents to the Integrin Alpha-11 subunit, and uses thereofLUNDGREN-AKERLUND EVY·Filed 2007·Application pending·0 cites
- 1846US2009232777A1Expansion and Differentiation of Mesenchymal Stem CellsLUNDGREN-AKERLUND EVY·Filed 2007·Application pending·0 cites
- 1935US2006123495A1Knockout mice and their useGULLBERG DONALD·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Evy Lundgren-Akerlund files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →